The Latest Cardiac and Vascular News
DENVER, May 10, 2023 /PRNewswire/ — ViewRay, Inc. (Nasdaq: VRAY) (the “Company”) today announced financial results for the first quarter ended March 31, 2023. First Quarter 2023 Highlights Total revenue for the first quarter 2023 was approximately $22.5 million, primarily from three revenue units, compared to approximately $18.9 million, primarily from three revenue units, in the […]
DENVER, April 13, 2023 /PRNewswire/ — ViewRay, Inc. (Nasdaq: VRAY) (the “Company”) today provided a business update and announced preliminary financial results for the quarter ended March 31, 2023. The preliminary results have not been audited and are subject to change. First Quarter 2023 Preliminary Results and Key Points (Unaudited) Received 13 new orders […]
DENVER, Feb. 27, 2023 /PRNewswire/ — ViewRay, Inc. (Nasdaq: VRAY) (the “Company”) today announced financial results for the fourth quarter and full fiscal year ended December 31, 2022. Full Year 2022 Highlights Total revenue of $102.2 million primarily from 16 revenue units including one upgrade, compared to 2021 revenue of approximately $70.1 million, primarily from ten revenue […]
DENVER, Jan. 9, 2023 /PRNewswire/ — ViewRay, Inc. (Nasdaq: VRAY) (the “Company”) today announced preliminary financial results for the fourth quarter and full fiscal year ended December 31, 2022. The preliminary results have not been audited and are subject to change. Selected Fourth Quarter and Full Year 2022 Preliminary Results and Other Data (Unaudited) […]
Facility includes senior secured term loan of up to $100 million and a revolving line of credit of up to $25 million DENVER, Nov. 14, 2022 /PRNewswire/ — ViewRay, Inc. (Nasdaq: VRAY) (the “Company”) today announced that it has entered into a new five-year loan facility agreement with MidCap Financial and Silicon Valley Bank (the “Agreement”). […]
DENVER, Nov. 1, 2022 /PRNewswire/ — ViewRay, Inc. (Nasdaq: VRAY) (the “Company”) today announced financial results for the third quarter ended September 30, 2022. Third Quarter 2022 Highlights Total revenue for the third quarter 2022 was approximately $26.5 million, primarily from four revenue units, compared to approximately $19.2 million, primarily from three revenue units, in the third […]
Leading Clinical Training Hospital Aims to Begin MRIdian Patient Treatments in 2021 CLEVELAND, Dec. 21, 2020 /PRNewswire/ — ViewRay, Inc. (Nasdaq: VRAY) announced today that Catharina Hospital in Eindhoven, Netherlands, also known as Catharina Ziekenhuis, has purchased a MRIdian® Linac MRI-Guided Therapy System, a cutting-edge radiation therapy device that combines the latest innovations in precision radiation delivery […]
CLEVELAND, Jan. 22, 2019 /PRNewswire/ — ViewRay, Inc. (Nasdaq: VRAY) announced today the five-year anniversary of patient treatments with MRIdian MRI-guided radiation therapy at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, Missouri. As one of the world’s leading cancer centers, Siteman is known for pioneering the advancement and adoption of […]
CLEVELAND, Jan. 7, 2019 /PRNewswire/ — ViewRay, Inc. (Nasdaq: VRAY) today announced preliminary results for the fourth quarter and full fiscal year ended December 31, 2018. The preliminary results have not been audited and are subject to change. Selected Fourth Quarter and Full Year 2018 Preliminary Highlights: Recognized 3 revenue units and 1 system upgrade […]
New Directors Bring Extensive Medical Device Experience to the Board [07-February-2018] CLEVELAND, Feb. 7, 2018 /PRNewswire/ — ViewRay (Nasdaq: VRAY), maker of the world’s first and only clinical MRI-guided radiation therapy system, announced today the appointment of medical device industry veterans Scott Huennekens and Daniel Moore to the Company’s board of directors, […]
